Cancer Research UK scheme secures £280m buy-in with Standard Life

BPA deal secures the benefits of 2,800 scheme members

Holly Roach
clock • 2 min read
Cancer Research UK scheme secures £280m buy-in with Standard Life

The Cancer Research UK Pension Scheme has completed a £280m buy-in deal with Standard Life.

The bulk purchase annuity (BPA) transaction – completed in March using a "bespoke offering" – secures the benefits of 2,800 scheme members. Mercer was lead transaction adviser to the trustee, wh...

To continue reading this article...

Join Professional Pensions

Become a Professional Pensions Lite Member today

  • Three complimentary articles per month covering the latest real-time news, analysis and opinion from the industry
  • Receive important and breaking news stories via our two daily news alerts
  • Hear from industry experts and other forward-thinking leaders

Are you a trustee, investment consultant or in-house pension and benefit scheme professional? You can apply for full complimentary access here

Join now

 

Already a Professional Pensions
member?

Login

More on Risk Reduction

The era of choice in DB endgames

The era of choice in DB endgames

Rosie Twist asks how trustees should consider the differences between their options

Rosie Twist
clock 08 May 2026 • 5 min read
M&G expects BPA volumes to continue year-on-year growth following with-profits launch

M&G expects BPA volumes to continue year-on-year growth following with-profits launch

Firm’s Q1 trading update says BPA growth will be weighted towards second half of year

Jonathan Stapleton
clock 07 May 2026 • 2 min read
Bakkavor Pension Scheme completes £160m buy-in with Rothesay

Bakkavor Pension Scheme completes £160m buy-in with Rothesay

Transaction secures the benefits of all 2,216 scheme members

Holly Roach
clock 05 May 2026 • 2 min read
Trustpilot